Skip to main content
. 2015 Aug 19;2(3):261–271. doi: 10.1007/s40801-015-0031-8

Table 1.

High-risk medicines and medicine combinations included in this study

High-risk category Medicine details
NSAID plus Angiotensin conversing enzyme inhibitor/angiotensin II receptor antagonist and diuretic
eGFR below 60 mL/min
Heart failure
Warfarin
Age over 75 years and no PPI protection
Warfarin plus Antiplatelet
NSAID
Macrolide
Quinolone
Metronidazole
Azole antifungal
Heart failure plus Glitazone
NSAID
Tricyclic antidepressant
Aged over 60 years and taking Benzodiazepines/hypnotics
Tricyclic antidepressants
Antipsychotics (including prochlorperazine for nausea/vertigo)
Sedating antihistamines
Anticholinergics (see list below)
Antihypertensive plus diuretic
Digoxin
Anticholinergics with a clinically significant effect Amitriptyline
Amoxapine
Atropine
Benztropine
Chlorpheniramine
Chlorpromazine
Clemastine
Clomipramine
Clozapine
Darifenacin
Desipramine
Dicyclomine
Diphenhydramine
Doxepin
Flavoxate
Hydroxyzine
Hyoscyamine
Imipramine
Meclizine
Nortriptyline
Orphenadrine
Oxybutynin
Paroxetine
Perphenazine
Procyclidine
Promazine
Promethazine
Propentheline
Pyrilamine
Scopolamine
Tolterodine
Trifluoperazine
Trihexyphenidyl
Trimipramine

eGFR estimated glomerular filtration rate, NSAID non-steroidal anti-inflammatory drug, PPI proton pump inhibitor